Compare NSRX & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NSRX | MNY |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | Israel | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.4M | 54.5M |
| IPO Year | 2025 | N/A |
| Metric | NSRX | MNY |
|---|---|---|
| Price | $6.80 | $1.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $22.00 | $4.00 |
| AVG Volume (30 Days) | 2.8K | ★ 86.8K |
| Earning Date | 12-26-2025 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,182,746.00 |
| Revenue This Year | N/A | $11.26 |
| Revenue Next Year | N/A | $20.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.90 | $0.55 |
| 52 Week High | $9.99 | $2.40 |
| Indicator | NSRX | MNY |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 48.29 |
| Support Level | N/A | $1.20 |
| Resistance Level | N/A | $1.60 |
| Average True Range (ATR) | 0.00 | 0.11 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 22.50 |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.